Poseida Therapeutics, Inc. (PSTX) financial statements (2022 and earlier)

Company profile

Business Address 9390 TOWNE CENTRE DRIVE
SAN DIEGO, CA 92121
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:206,300197,811237,300270,000309,200341,500167,100
Cash and cash equivalents206,325197,811199,693169,79583,96666,271147,133
Short-term investments  37,568100,165225,186275,18619,998
Other undisclosed cash, cash equivalents, and short-term investments(25) 39404843(31)
Prepaid expense4,809   4,056  
Other undisclosed current assets2,7646,9883,0723,9967405,7776,046
Total current assets:213,873204,799240,372273,996313,996347,277173,146
Noncurrent Assets
Operating lease, right-of-use asset26,17725,18726,06926,93924,98625,07020,145
Property, plant and equipment22,05022,44223,29623,23623,33623,72822,085
Intangible assets, net (including goodwill)5,5485,5485,5485,5485,5485,5485,548
Goodwill4,2284,2284,2284,2284,2284,2284,228
Intangible assets, net (excluding goodwill)1,3201,3201,3201,3201,3201,3201,320
Deferred costs      1,880
Other noncurrent assets1,6613,9613,8263,6183,6183,5483,548
Total noncurrent assets:55,43657,13858,73959,34157,48857,89453,206
TOTAL ASSETS:269,309261,937299,111333,337371,484405,171226,352
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,20912,29811,1527,7389,3958,9089,259
Accounts payable8,9613,6444,5062,4877631,2561,562
Accrued liabilities2,4882,7921,9701,9321,8392,8374,558
Employee-related liabilities8,7605,8624,6763,3196,7934,8153,139
Deferred revenue4,497      
Debt   3,000   
Other undisclosed current liabilities18,62919,49920,84717,05120,63020,86219,633
Total current liabilities:43,33531,79731,99927,78930,02529,77028,892
Noncurrent Liabilities
Long-term debt and lease obligation54,86154,69655,35952,98554,50754,67450,178
Long-term debt, excluding current maturities29,35729,31429,27326,20829,13329,05928,990
Operating lease, liability25,50425,38226,08626,77725,37425,61521,188
Liabilities, other than long-term debt10,9101,5321,4221,3221,2291,1361,047
Deferred revenue9,265      
Deferred income tax liabilities55555555555555
Other liabilities1,5901,4771,3671,2671,1741,081992
Other undisclosed noncurrent liabilities3,99223,75523,75523,75523,75523,75525,225
Total noncurrent liabilities:69,76379,98380,53678,06279,49179,56576,450
Total liabilities:113,098111,780112,535105,851109,516109,335105,342
Temporary equity, carrying amount      326,313
Stockholders' equity
Stockholders' equity attributable to parent156,211150,157186,576227,486261,968295,836(205,303)
Common stock6666662
Additional paid in capital563,064558,479552,473547,664543,842541,6055,997
Accumulated other comprehensive income (loss)  1155(39)20
Accumulated deficit(406,859)(408,328)(365,904)(320,199)(281,885)(245,736)(211,322)
Total stockholders' equity:156,211150,157186,576227,486261,968295,836(205,303)
TOTAL LIABILITIES AND EQUITY:269,309261,937299,111333,337371,484405,171226,352

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues31,238      
Operating expenses(48,716)(41,590)(44,879)(37,464)(35,360)(33,474)(29,446)
Other undisclosed operating income31,238      
Operating loss:(17,478)(41,590)(44,879)(37,464)(35,360)(33,474)(29,446)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
19,787317(12)64(92)(90)
Interest and debt expense(840)(837)(843)(838)(852)(848)(892)
Net income (loss) available to common stockholders, diluted:1,469(42,424)(45,705)(38,314)(36,148)(34,414)(30,428)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):1,469(42,424)(45,705)(38,314)(36,148)(34,414)(30,428)
Other comprehensive income (loss)    44(59)(110)
Comprehensive income (loss):1,469(42,424)(45,705)(38,314)(36,104)(34,473)(30,538)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (1)(14)10   
Comprehensive income (loss), net of tax, attributable to parent:1,469(42,425)(45,719)(38,304)(36,104)(34,473)(30,538)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: